Makhmudova, U.
Schatz, U.
Perakakis, N.
Kassner, U.
Schumann, F.
Axthelm, C.
Stürzebecher, P.
Sinning, D. L.
Doevelaar, A.
Rohn, B.
Westhoff, T.
Vogt, A.
Scholl, M.
Kästner, U.
Geiling, J.-A.
Stach, K.
Mensch, J.
Lorenz, E.
Paitazoglou, C.
Eitel, I.
Baessler, A.
Steinhagen-Thiessen, E.
Koenig, W.
Schulze, P. C.
Landmesser, U.
Laufs, U.
Weingärtner, Oliver http://orcid.org/0000-0002-0236-206X
,
Makhmudova, U.
Schatz, U.
Perakakis, N.
Kassner, U.
Schumann, F.
Axthelm, C.
Stürzebecher, P.
Sinning, D. L.
Doevelaar, A.
Rohn, B.
Westhoff, T.
Vogt, A.
Scholl, M.
Kästner, U.
Geiling, J.-A.
Stach, K.
Mensch, J.
Lorenz, E.
Paitazoglou, C.
Eitel, I.
Baessler, A.
Steinhagen-Thiessen, E.
Koenig, W.
Schulze, P. C.
Landmesser, U.
Laufs, U.
Weingärtner, Oliver http://orcid.org/0000-0002-0236-206X
Funding for this research was provided by:
Universitätsklinikum Jena
Article History
Received: 29 March 2023
Accepted: 14 June 2023
First Online: 9 July 2023
Declarations
:
: P.S., F.S. and G.J-A report no conflict of interest. U.M. reports speaker fee from the German Lipid Association, non-financial cooperation with Novartis and advisory board honoraria from Sanofi outside the submitted work. O.W. reports fees from Novartis, Daiichi Sankyo, Amgen, Sanofi, Fresenius, Novo Nordisk, Hexal, Akcea Therapeutics, Sobi and Pfizer outside the submitted work. W.K. reports consulting fees from AstraZeneca, Novartis, Pfizer, The Medicines Company, DalCor, Kowa, Amgen, Corvidia, Daiichi-Sankyo, Genentech, Novo Nordisk, Esperion, OMEICOS, LIB Therapeutics, TenSixteen Bio, New Amsterdam Pharma, speaker honoraria from Amgen, Novartis, Berlin-Chemie, Sanofi, and Bristol-Myers Squibb, grants and non-financial support from Abbott, Roche Diagnostics, Beckmann, and Singulex outside the submitted work. T.W. reports research grants and/or speakers’ honoraria and/or advisory boards’ honoraria from Amgen, Daiichi-Sankyo, Novartis, and Sanofi Aventis outside the submitted work. U.L. reports fees from Novartis, Daiichi Sankyo, Amgen, Sanofi outside the submitted work. N.P reports advisory board honoraria from Bayer Vital GmbH and speaker honoraria from Novo Nordisk, CardioMetabolic Health Conference and The Metabolic Institute of America, GWT outside the submitted work. A.V. reports fees from Amgen, Daiichi Sankyo, Novartis, Regeneron/Sanofi outside the submitted work. D.S. reports speaker and advisory board honoraria from Amgen, Novartis, and Daiichi-Sankyo, consulting fees from Sanofi, and participation in clinical trials with Novartis, outside the submitted work. E.S-T. reports fees for lectures and/or advisory board honoraria from Fresenius Medical Care. Daiichi-Sankyo, Novartis, Amgen, Amarin, Sanofi, Pfizer outside the submitted work. U.S. reports speaker and advisor honoraria from Amgen, Amarin, Astra Zeneca, Berlin Chemie, Daiichi Sankyo, Lilly, Novartis, NovoNordisk, Sanofi Aventis outside the submitted work. U.K. reports fees from Amgen, Daiichi Sankyo, Novartis, Regeneron/Sanofi outside the submitted work. I. E. reports speaker honoraria from Novartis, Daiichi-Sankyo, Sanofi, Bristol-Myers Squibb, Bayer, Boehringer-Ingelheim and Astra Zeneca outside the submitted work. E.L. reports speaker fees from AMGEN, Novartis and Sanofi outside the submitted work.